Cargando…

The need to tailor the omission of axillary lymph node dissection to patients with good prognosis and sentinel node micro‐metastases

BACKGROUND: Results of IBCSG‐23‐01‐trial which included breast cancer patients with involved sentinel nodes (SN) by isolated‐tumor‐cells or micro‐metastases supported the non‐inferiority of completion axillary‐lymph‐node‐dissection (cALND) omission. However, current data are considered insufficient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Houvenaeghel, Gilles, de Nonneville, Alexandre, Chopin, Nicolas, Classe, Jean‐Marc, Mazouni, Chafika, Chauvet, Marie‐Pierre, Reyal, Fabien, Tunon de Lara, Christine, Jouve, Eva, Rouzier, Roman, Daraï, Emile, Gimbergues, Pierre, Coutant, Charles, Azuar, Anne Sophie, Villet, Richard, Crochet, Patrice, Rua, Sandrine, Bannier, Marie, Cohen, Monique, Boher, Jean‐Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972015/ https://www.ncbi.nlm.nih.gov/pubmed/36127853 http://dx.doi.org/10.1002/cam4.5257

Ejemplares similares

Lymph node positivity in different early breast carcinoma phenotypes: a predictive model
por: Houvenaeghel, Gilles, et al.
Publicado: (2019)

Early breast cancer in women aged 35 years or younger: A large national multicenter French population-based case control-matched analysis
por: Dufour, Ondine, et al.
Publicado: (2023)

Negative Survival Impact of Occult Lymph Node Involvement in Small HER2-Positive Early Breast Cancer Treated by Up-Front Surgery
por: Houvenaeghel, Gilles, et al.
Publicado: (2023)

Lack of prognostic impact of sentinel node micro-metastases in endocrine receptor-positive early breast cancer: results from a large multicenter cohort(☆)
por: Houvenaeghel, G., et al.
Publicado: (2021)

Lymphovascular invasion has a significant prognostic impact in patients with early breast cancer, results from a large, national, multicenter, retrospective cohort study
por: Houvenaeghel, G., et al.
Publicado: (2021)

Axillary lymph node micrometastases decrease triple-negative early breast cancer survival
por: Houvenaeghel, G, et al.
Publicado: (2016)

Sentinel node involvement with or without completion axillary lymph node dissection: treatment and pathologic results of randomized SERC trial
por: Houvenaeghel, Gilles, et al.
Publicado: (2021)

Eligibility criteria for intraoperative radiotherapy for breast cancer: study employing 12,025 patients treated in two cohorts
por: Ziouèche-Mottet, Amira, et al.
Publicado: (2014)

Overview of the pathological results and treatment characteristics in the first 1000 patients randomized in the SERC trial: axillary dissection versus no axillary dissection in patients with involved sentinel node
por: Houvenaeghel, Gilles, et al.
Publicado: (2018)

Evaluation of the Effects of Pasireotide LAR Administration on Lymphocele Prevention after Axillary Node Dissection for Breast Cancer: Results of a Randomized Non-Comparative Phase 2 Study
por: Chéreau, Elisabeth, et al.
Publicado: (2016)

Ultrastaging of lymph node in uterine cancers
por: Bézu, Corinne, et al.
Publicado: (2010)

External Validation of the SERC Trial Population: Comparison with the Multicenter French Cohort, the Swedish and SENOMIC Trial Populations for Breast Cancer Patients with Sentinel Node Micro-Metastasis
por: Houvenaeghel, Gilles, et al.
Publicado: (2020)

Exclusive intraoperative radiotherapy for invasive breast cancer in elderly patients (>70 years): proportion of eligible patients and local recurrence-free survival
por: Lambaudie, Eric, et al.
Publicado: (2016)

Multicenter prospective evaluation of the reliability of the combined use of two models to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: the MSKCC nomogram and the Tenon score. Results of the NOTEGS study
por: Rouzier, Roman, et al.
Publicado: (2017)

Does the use of the 2009 FIGO classification of endometrial cancer impact on indications of the sentinel node biopsy?
por: Ballester, Marcos, et al.
Publicado: (2010)

Contribution of pelvic and para-aortic lymphadenectomy with sentinel node biopsy in patients with IB2–IIB cervical cancer
por: Chéreau, E, et al.
Publicado: (2012)

Associated Lichen Sclerosis Increases the Risk of Lymph Node Metastases of Vulvar Cancer
por: Dabi, Yohann, et al.
Publicado: (2020)

Non-Sentinel Lymph Node Metastasis Prediction in Breast Cancer with Metastatic Sentinel Lymph Node: Impact of Molecular Subtypes Classification
por: Reyal, Fabien, et al.
Publicado: (2012)

The Role of Sentinel Lymph Node Biopsy and Factors Associated with Invasion in Extensive DCIS of the Breast Treated by Mastectomy: The Cinnamome Prospective Multicenter Study
por: Tunon-de-Lara, Christine, et al.
Publicado: (2015)

Near-Infrared Fluorescence Axillary Reverse Mapping (ARM) Procedure in Invasive Breast Cancer: Relationship between Fluorescence Signal in ARM Lymph Nodes and Clinical Outcomes
por: Abbaci, Muriel, et al.
Publicado: (2022)

Omission of axillary sentinel lymph node biopsy in early invasive breast cancer
por: Reimer, Toralf
Publicado: (2023)

Omission of axillary lymph node dissection in patients who underwent total mastectomy with 1 or 2 metastatic lymph nodes
por: Kim, Bong Kyun, et al.
Publicado: (2020)

Enhanced recovery after surgery program in Gynaecologic Oncological surgery in a minimally invasive techniques expert center
por: Lambaudie, Eric, et al.
Publicado: (2017)

Mastectomy and Immediate Breast Reconstruction with Pre-Pectoral or Sub-Pectoral Implant: Assessing Clinical Practice, Post-Surgical Outcomes, Patient’s Satisfaction and Cost
por: Houvenaeghel, Gilles, et al.
Publicado: (2022)

Omission of axillary lymph node dissection after neoadjuvant chemotherapy for clinically node‐positive breast cancer: How can we select patients?
por: van Zeeland, Marianne, et al.
Publicado: (2020)

Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy
por: Bonsang-Kitzis, Hélène, et al.
Publicado: (2015)

Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy
por: Bonsang-Kitzis, Hélène, et al.
Publicado: (2016)

Therapeutic Benefit of Systematic Lymphadenectomy in Node-Negative Uterine-Confined Endometrioid Endometrial Carcinoma: Omission of Adjuvant Therapy
por: Otsuka, Isao
Publicado: (2022)

Neoadjuvant Chemotherapy for Breast Cancer: Evolution of Clinical Practice in a French Cancer Center Over 16 Years and Pathologic Response Rates According to Tumor Subtypes and Clinical Tumor Size: Retrospective Cohort Study
por: Houvenaeghel, Gilles, et al.
Publicado: (2022)

Omission
Publicado: (1881)

An Omission
Publicado: (1885)

Omission
Publicado: (1867)

Omission
Publicado: (1882)

An Omission
Publicado: (1875)

Omission
Publicado: (1858)

Systematic versus sentinel-lymph-node-driven axillary-lymph-node dissection in clinically node-negative patients with operable breast cancer. Results of the GF-GS01 randomized trial
por: Roy, P., et al.
Publicado: (2018)

Value of non-coding RNAs to assess lymph node status in cervical cancer
por: Dabi, Yohann, et al.
Publicado: (2023)

The Molecular Subtype Classification Is a Determinant of Sentinel Node Positivity in Early Breast Carcinoma
por: Reyal, Fabien, et al.
Publicado: (2011)

Protein expression, survival and docetaxel benefit in node-positive breast cancer treated with adjuvant chemotherapy in the FNCLCC - PACS 01 randomized trial
por: Jacquemier, Jocelyne, et al.
Publicado: (2011)

Feasibility of sentinel lymph node biopsy omission after integration of (18)F-FDG dedicated lymph node PET in early breast cancer: a prospective phase II trial
por: Li, Junjie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vd3muhpgm6oro6dvkgo1j080kp